Webinar on

Diabetes and Metabolism

Diabetes Metabolism 2020

Theme: Collection of advanced therapies: Prevention of Diabetes & Metabolic Syndrome

Webinar on Diabetes and Metabolism 2020 is designed to provide an exclusive international forum for all the participants and entrants to introduce and talk about the latest advancements, challenges encountered, trends, concerns, applications and the solutions taken up for mitigating diabetes and metabolism. The webinar  will be held on May 18, 2020 at Toronto, Canada. Diabetes Metabolism 2020 will provide a concentrated learning on circulation of information; chances to arrange and talk about science, drug on diabetes, medicinal services and the current advances and innovations related to diabetes and metabolism. The main center of focus will be at the latest updates on clinical and basic scientific advances in key areas of diabetes, obesity and metabolism, important historical overviews, discussion of controversial issues and opinions from prominent researchers and clinicians regarding translational and basic research closely related metabolic disorders and the conference will be also concerned with treatment and management of issues related to patient care. Diabetes Metabolism 2020 incorporates plenary lectures, keynote talks, courses by eminent personalities from around the world.


Session 1: Obesity, Diabetes and Metabolic Syndrome

Obesity is where a man has collected so much muscle versus fat that it may negatively affect their well-being. In the event that a man's body weight is no less than 20% higher than it ought to be, he or she is viewed as corpulent. On the off chance that your Body Mass Index (BMI) is in the vicinity of 25 and 29.9, you are viewed as overweight. On the off chance that your BMI is 30 or over you are viewed as fat. Diabetes mellitus is a ceaseless, long-lasting condition that influences your body's capacity to utilize the vitality found in nourishment. There is three noteworthy diabetes are of three sorts they are type 1 diabetes, type 2 diabetes, and gestational diabetes. A wide range of diabetes mellitus has something in like manner. Ordinarily, your body separates the sugars and starches you eat into a unique sugar called glucose.

Session 2: Diabetes Wound Care and Management

Wound recuperating gets moderate in diabetic patients because of various factors, for example, High glucose levels (When your glucose level is higher than ordinary, it keeps supplements and oxygen from invigorating cells which keeps your resistant framework from working effectively and in the long run builds aggravation in the body's cells. Neuropathy (This is the harm caused to the nerve cells because of consistent high glucose levels. This may prompted lose sensation in the influenced regions. Usually in the hands and feet of the diabetic patients. When it occurs, one will be unable to feel wounds when they happen. This is one noteworthy motivation behind why foot wounds have a tendency to be more typical in individuals with diabetes.

Session 3: Endocrinology and Metabolic Syndrome-Metabolic Disorder

Endocrine disorders involve the body’s over- or under-production of certain hormones, while metabolic disorders affect the body’s ability to process certain nutrients and vitamins. Endocrine disorders include hypothyroidism, congenital adrenal hyperplasia, diseases of the parathyroid gland, diabetes mellitus, diseases of the adrenal glands (including Cushing’s syndrome and Addison’s disease), and ovarian dysfunction (including polycystic ovary syndrome), among others. Behavioural endocrinology is the study of hormonal processes and neuroendocrine systems that influence or regulate behaviour. Endocrinology includes the wide area that not only affects our endocrine system, but also has effects on skin which shows indirectly involvement of dermatology.

Session 4: Pathophysiology: Endocrinology, Diabetes and Metabolic Syndrome

Diabetes mellitus (DM) is a group of diseases characterized by a disrupted carbohydrate metabolism leading to elevated blood glucose levels (hyperglycemia) and secretion of glucose in the urine (glycosuria) as a result of insufficient production or functioning of the pancreatic hormone insulin, combined with a number of yet undefined predisposing factors. Chronic hyperglycemia causes long-term damage, dysfunction and failures of various cells, tissues and organs. This may also add considerable amount of time educating patients and families on proper dietary, exercise and lifestyle habits to keep symptoms under control. Go along with us to extend your insight on this session at diabetes metabolism conference.

Session 5: Cardio Metabolic Disease

In the previous decade, there has been an emotional increment in constant infections like diabetes, hypertension, and corpulence in industrialized countries as well as in creating countries with developing economies. With the heightening of stoutness, diabetes, and hypertension, there has been a parallel increment in the frequency and commonness of cardiometabolic difficulties. Cardio metabolic inconveniences are multifactorial ailments, and a wide range of various variables incorporating changes in living situations, diets, ways of life, hereditary, and epigenetic elements might be included. Albeit critical steps have been made in explaining the multifaceted systems related to numerous cardiometabolic inconveniences, much still must be finished. For instance, examines which divulge novel instruments involved in cardio-metabolic sicknesses may open new helpful skylines.

Session 6: Diabetes Diet, Eating, & Physical Activity`

Healthy eating is the major part of managing diabetes. Eating the right foods and following other lifestyle behaviours that develop healthy blood sugar and insulin levels will give you the best chance at avoiding diabetes. There are a few herbs that may help increase insulin sensitivity and reduce the likelihood of diabetes progression which are curcumin and berberine. The major goal in treating type 1 and type 2 diabetes is to regulate blood sugar (glucose) levels within the normal range. Type 1 diabetes is treated with insulin, exercise, and a healthy diet. Type 2 diabetes is treated with weight reduction, a type 2 diabetes diet, and exercise, diabetes medications (oral or injected) are prescribed when these measures fail to control the elevated blood sugars of type 2 diabetes. If other medications become ineffective treatment with insulin may be initiated.

Session 7: Diabetes Diagnosis and Treatment

Health Care professionals can diagnose diabetes, prediabetes, and gestational diabetes through blood tests. The blood tests show if your blood glucose, also called blood sugar, is too high or low. Some people will not have any direct symptoms but may have some indirect risk factors for diabetes and need to be tested. Testing allows health care professionals to find diabetes sooner and work with their patients to manage diabetes and prevent complications. Doctors usually investigates type 1 diabetes in children and young adults. Because type 1 diabetes can run in families, a study called Trial Net offers free testing to family members of people with the disease, even if they don’t have symptoms. Experts suggests testing children between the ages of 10 and 18 who are overweight or obese and have at least two other risk factors for developing diabetes.

Session 8: Paediatric Diabetes, Diabetes Eye Diseases, Paediatric Endocrinology and Gynaecology Endocrinology

Pediatric diabetes is a condition over know youngsters which deals with endocrine organs disorder, like assortments about physical development and sexual enhancement for adolescence, diabetes also one among them. Pediatric type 1 diabetes is a ceaseless illness depicted toward those bodies having inability to process insulin response due to immune decimation of beta cells in the pancreas. Pediatric Endocrinology  is a subspecialty of pediatrics dealing with metabolic and endocrine disorders  in children. The most common disease of the speciality is type 1 diabetes , which usually accounts for at least 50% of a typical clinical practice. The next most common problem is growth disorders, especially those amenable to growth hormone  treatment. Pediatric endocrinologists are usually the primary physicians involved in the medical care of infants  and children with intersex disorders.

Session 9: Advanced Treatments for Diabetes

Blood glucose (blood sugar) monitoring is the main tool used to check diabetes of an individual. This helps you to check your blood glucose level at any one time. The artificial pancreas bridges the gap between two pieces of diabetes technology that already exist: the insulin pump and the continuous glucose monitor (CGM). Relatively, a large percentage of world population is affected by diabetes mellitus, out of which approximately 5-10% of people are with type 1 diabetes while the remaining 90% of people are with type 2. Insulin administration is initially important for type 1 patients while it is required at later stage by the patients of type 2. Various advanced innovations have been playing a major role in the reduction of patients carrying diabetes.

• Targeting the microbiome

• The needle-free revolution

• Stimulating insulin production

• Treatment processes highlights

• Diabetes and metabolic syndrome

• Replacing missing cells with cell therapy

• Attacking the origin with immunotherapy

• Automated treatment with an artificial pancreas

Session 10: Diabetic Nephropathy and Urine

Diabetic nephropathy is the disease/ damaged caused by diabetes to your kidney, which in severe cases can lead to kidney failure. The waste from our blood is filtered by the tiny blood vessels present in our kidney, they can be destroyed by high blood sugar level in our body. The body retains excess water and salts than required leading to weight gain and ankle swelling. This leads to malfunction or kidney failure in later stages. No symptoms are shown in earlier stages so, regular urine tests are required to detect any kidney damage. Diabetes may also lead to damage to nerves, which can lead to difficulty in emptying your bladder and creating pressure injuring your kidney. Long time retention of urine in bladder leads to infections as bacterial growth in urine with high blood sugar level is high. About 30% of patients with Type 1 diabetes and 10 to 40 % of those with Type 2 diabetes gradually will suffer from kidney failure.

Global Market for Diabetes:

The global diabetes care drugs market is segmented by category (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs), by segment (basal or long-acting, bolus or fast-acting, traditional human insulin drugs, insulin biosimilars, GLP-1 receptor agonists, Alpha-Glucosidase inhibitors, DPP-4 inhibitors, and SGLT-2 inhibitors) and by geography.

Market Overview:

•    Approximately 10% of all diabetes cases are Type 1, and approximately 90% of all cases of diabetes worldwide are of Type 2.
•    The global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. In 2016, an estimated 1.6 million deaths were directly caused by diabetes.
•    Almost half of all deaths attributable to high blood glucose occur before the age of 70 years. It is estimated that diabetes was the seventh leading cause of death in 2016.

Scope and importance:

Diabetes is one of the most emerging diseases, which is becoming very common nowadays. Patients with high blood sugar will experience polyuria (frequent urination), meeting thirsty (polydipsia) and hungry (polyphagia). With the change in life style; our endocrine system of the body is getting disturbed. In order to get innovative, the Diabetes Metabolism Conference will focus on the latest and exciting innovations in all areas of diabetes and metabolism based research offering a unique opportunity for international explorers to assemble, network, talk and grasp new scientific innovations and ideas to prevent diabetes related ailments. To allocate advance researches, developments, druggists, scientists, technology challenges and improvement and alternative therapies, this meeting forms an excellent learning.

Business and Economics of Diabetes:

Diabetes has become a lifestyle-related disease as it afflicts young and old. As the proportion of patients are growing rapidly across the globe, there has never been a stronger and more urgent need for novel therapeutic measures in clinical and preclinical evaluation, that arrest the growth of the disease. The diabetes market, consisting of mainly Type 1 and Type 2 diabetes, is large and growing significantly. The global market value for diabetes therapies and diagnostics has aroused to $48.5 billion. The largest segment of the market, insulin products, is worth $20.8 billion in recent days, including administration and diagnostic devices. Diabetes monitoring devices and other related equipment, the second-largest market is established with an investment of $13.5 billion which was proposed for $11.3. The fastest-growing segment of oral diabetic problems of hypoglycemia drugs manufacturing funding is $14.13 in present time scenario of the diabetes market.

Diabetes in America:

Diabetes remains the 7th leading cause of death in the United States in 2015, with 79,535 death certificates listing it as the underlying cause of death, and a total of 252,806 death certificates listing diabetes as an underlying or contributing cause of death.

•    In 2015, 30.3 million Americans, or 9.4% of the population, had diabetes. Approximately 1.25 million American children and adults have type-1 diabetes.
•    North America is the largest consumption place, with a consumption market share nearly 31.2% in 2017.

Diabetes in Asia:

The prevalence of diabetes is increasing worldwide, particularly in Asia. The Diabetes Atlas published in 2013 reported that 366 million of individuals are affected by diabetes, and 36% of those affected live in the Western Pacific region, with a significant proportion in East Asia.
•    The Asia-Pacific market for diabetes drugs is estimated to value USD 23.8 billion in 2019, and the market is expected to grow at the CAGR of 4.82%, during the forecast period.

Diabetes in Middle East and Africa:

According to the International Diabetes Federation Atlas, 19.3 percent of adults aged 20 to 79 in the United Arab Emirates are diabetic. In Bahrain, the percentage rises to 19.6—and the statistic jumps to 20 percent for Kuwait, Qatar, and Saudi Arabia. According to the IDF Diabetes Atlas 8th Edition, approximately 38.7 million adults aged 20-79 years were living with diabetes in the Middle East and North Africa Region in 2017. Over two-thirds (67.3%) of adults with diabetes live in urban areas.
•    In Middle East & Africa (MEA), 15.51 million people are suffering from diabetes, and this population is expected to increase in the forecast period with a CAGR of 4.46%.
•    The Middle East & Africa diabetes drugs market (henceforth, referred to as the market studied) was valued at USD 2793.99 million in 2018, and it is expected to witness a CAGR of 6.48% during the forecast period 2019 - 2024, primarily due to the growing geriatric population.

Diabetes in Europe:

There are about 60 million people with diabetes in the European Region, or about 10.3% of men and 9.6% of women aged 25 years and over. Prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity.

•    The European diabetes devices market is expected to record a high CAGR of 7.51% during the forecast period (2019 - 2024), due to the growing prevalence of diabetes, growing geriatric population levels, unhealthy diet, and increasing levels of physical inactivity.

Rising Prevalence of Diabetes

•    The market size, in 2017, for the global diabetes drugs market was registered to be USD 67.5 billion, and the market is expected to record a CAGR of 5.65% during the forecast period, 2019-2024.
•    As per a WHO report, the global prevalence of diabetes among adults of over 18 years had accelerated from about 4.7%, in 1980, to over 8.5%, in 2014.
•    Diabetes prevalence has been rising rapidly in the middle- and low-income countries. In 2015, about 1.6 million deaths were directly associated with diabetes, which was around 2.2 million in 2012.
•    Almost half of all deaths attributable to high blood glucose occur before the age of 70 years. WHO projects that diabetes is likely to be the seventh leading cause of death by 2030.

Societies Associated with Diabetes Care:

•    Endocrine Society Australia, Australia
•    American Diabetes Association, Virginia
•    European Society of Endocrinology, UK
•    British Society for Neuroendocrinology, London
•    International Neuroendocrine Federation, Canada
•    Association of British Clinical Diabetologist, UK
•    International Society of Endocrinology, Switzerland
•    Panhellenic Association of Endocrinologists, Greece
•    Spanish Society of Endocrinology and Nutrition, Spain
•    International Society of Psychoneuroendocrinology, Italy
•    The American Association of Clinical Endocrinology, Florida
•    British Society for Paediatric Endocrinology and Diabetes, UK
•    British Association of Endocrine and Thyroid Surgeons, London
•    Royal Society of Medicine Endocrinology and Diabetes Section, London
•    Egyptian Association of  Endocrinology, Diabetes And Atherosclerosis, Egypt

Global Universities Associated with Diabetes and Endocrinology

America Region

•    University of Alabama, USA
•    Mayo Medical School, USA
•    University of Arizona, USA
•    University of Arizona, USA
•    University of Arkansas, USA
•    California Northstate University, USA
•    Charles R. Drew University of Medicine and Science, USA
•    Keck School of Medicine of University of Southern California, USA
•    Loma Linda University, USA
•    Stanford University, USA
•    University of California, USA
•    George Washington University, USA
•    Florida International University, USA
•    University of Florida, USA
•    University of Calgary, Canada
•    University of Western Ontario, Canada
•    University of Waterloo, Canada
•    University of Montreal, Canada
•    McMaster University, Canada
•    University of Alberta, Canada
•    University of Sao Paulo, Brazil
•    Federal University of Rio De Janeiro, Brazil
•    Sao Paulo State University, Brazil
•    Federal University of Sao Paulo, Brazil
•    Federal University of Rio Grande Do Sul, Brazil

Asia Region

•    The University of Tokyo, Japan
•    National University of Singapore, Singapore
•    Kyoto University, Japan
•    University of Hong Kong, Hong Kong
•    Peking University, China
•    Seoul National University, South Korea
•    National Taiwan University, Taiwan
•    Osaka University, Japan
•    Nanyang Technological University, Singapore
•    Sungkyunkwan University, South Korea
•    Universiti Malaya, Malaysia
•    Indian Institute of Science, India
•    Universiti Kebangsaan Malaysia, Malaysia
•    University of Indonesia, Indonesia
•    Indian Institute of Technology Bombay, India
•    The Hong Kong University of Science and Technology (HKUST), Hong Kong

Middle East Region

•    Arabian Gulf University, Bahrain
•    Faculty of Medicine Zagazig University, Egypt
•    Benha University, Egypt
•    Fayoum Faculty of Medicine, Egypt
•    Bushehr University of Medical Sciences, Iran
•    Dezful University of Medical Sciences, Iran
•    Fasa Faculty of Medical Sciences, Iran
•    University of Kerabala, Iraq
•    University of Duhok, Iraq
•    Thi Qar University, Iraq
•    Minia Medical School, Egypt
•    Royal College of Surgeons in Ireland, Bahrain
•    Fatemiye University of Medical Sciences, Iran
•    Assiut Faculty of Medicine, Egypt
•    Suez Canal Faculty of Medicine, Egypt

Europe Region

•    LMU Munich, Germany
•    Technical University of Munich, Germany
•    University of Leuven, Belgium
•    University of Amsterdam, Netherlands
•    Humboldt University of Berlin, Germany
•    Leiden University, Netherlands
•    Utrecht University, Netherlands
•    Erasmus University Rotterdam, Netherlands
•    RWTH Aachen University, Germany
•    University of Groningen, Netherlands
•    University of Copenhagen, Denmark
•    University of Barcelona, Spain
•    University of Helsinki, Finland

Global Diabetes-endocrinology Research Centers

•    Joslin Diabetes Center, USA
•    Diabetes Research Institute Foundation, USA
•    UCSF Diabetes Center, USA
•    Mayo Clinic, USA
•    Vanderbilt Diabetes Center, USA
•    Euradia, England
•    Dyna Health, Finland
•    Oxford Centre for Diabetes, Endocrinology and Metabolism, England
•    Lundberg Laboratory for Diabetes Research, Sweden
•    German Center for Diabetes Research, Sweden
•    Diabetes Complications Research Centre, Ireland
•    Dubai Diabetes Center, UAE
•    Diabetes Research Center, Japan
•    Imperial College London Diabetes Center, UAE
•    Hong Kong Institute of Diabetes and Obesity, China
•    Korea University Medical Center, South Korea
•    Tel Aviv Sourasky Medical Center, Israel
•    Sheba Medical Center, Israel
•    RAK Diabetes Center, UAE

Global Diabetes-Endocrinology Medicals/Hospitals

America Region

•    Cleveland Clinic, USA
•    Massachusetts General Hospital, USA
•    Johns Hopkins Hospital, USA
•    UCSF Medical Center, USA
•    New York-Presbyterian University Hospital of Columbia and Cornell, Canada
•    Yale-New Haven Hospital, USA
•    Northwestern Memorial Hospital, USA
•    UCLA Medical Center, Canada
•    University of Washington Medical Center, USA
•    Hospitals of the University of Pennsylvania-Penn Presbyterian, USA
•    Brigham and Women’s Hospital, USA
•    Florida Hospital Orlando, USA
•    Cedars-Sinai Medical Center, Canada
•    Barnes-Jewish Hospital/Washington University, USA
•    Beaumont Hospital, USA
•    Mount Sinai Hospital, USA
•    Froedtert Hospital and the Medical College of Wisconsin, USA
•    Lancaster General Hospital, USA
•    University of Kansas Hospital, USA
•    Hospital Municipal Mendez, Argentina

Asian Region

•    Royal Prince Alfred Hospital, Australia
•    Royal Melbourne Hospital, Australia
•    Waikato Hospital, New Zealand
•    Faculty of Medicine Siriraj Hospital, Thailand
•    Prince Court Medical Centre, Malaysia
•    Fortis C-DOC Hospital, India
•    S. L Raheja Hospital, India
•    Apollo Hospitals, India
•    Indraprastha Apollo Hospital, India
•    Manipal Hospital, India
•    Tongji Hospital, China
•    Peking University People's Hospital, China
•    Peking University First Hospital, China
•    Bumrungrad International Hospital, Thailand
•    Bangkok Hospital Medical Center, Thailand
•    Gleneagles Hospital, Singapore

Middle East Region

•    King Faisal Specialist Hospital & Research Centre, Saudi Arabia
•    Riyadh Military Hospital, Saudi Arabia
•    Kbb Istanbul, Turkey
•    Ankara Saglik Müdürlügü, Turkey
•    Medicana Hospital Group, Turkey
•    American Hospital, UAE
•    Bezmi Alem Valide Sultan Vakif Gureba E A Hastanesi, Turkey
•    Hille Yaffe Medical Center, Israel
•    Erfan Hospital, Saudi Arabia
•    Ankara Numone Hospital, Turkey
•    Zulekha Hospital, UAE
•    Denizli Devlet Hastanesi, Turkey
•    King Fahad Medical Ci, Saudi Arabia

Europe Region

•    Swiss Prevention Clinic, Switzerland
•    Klinik Pyramide Am See, Switzerland
•    Health Centre, Switzerland
•    Clinique Générale-Beaulieu, Switzerland
•    Klinik Im Park, Switzerland
•    Klinik Hirslanden, Switzerland
•    Klinik Beau-Site, Switzerland
•    Hirslanden Clinique La Colline, Switzerland
•    Salem-Spital, Switzerland
•    Hirslanden Klinik, Switzerland
•    w. Goethe university hospital, Germany

Global Diabetes-Endocrinology Companies

•    Abbott Diabetes Care, USA
•    Accu-Chek, USA
•    Arkray USA, USA
•    Bayer, USA
•    LifeScan, USA
•    Animas, USA
•    Asante Solutions, USA
•    Abbot Laboratories, USA
•    Amylin Pharmaceuticals, USA
•    Aventis Pharmaceuticals, USA
•    Becton-Dickinson, USA
•    Bristol-Myers Squibb, USA
•    Novo Nordisk, USA
•    Pfizer, USA
•    SmithKline Beecham, USA
•    Takeda Pharmaceuticals, USA
•    Valeant, USA
•    Euradia, UK
•    MedTech Europe, Belgium
•    Cellnovo, France
•    Novo-Nordisk, Denmark
•    Acino, France
•    Thio Matrix -Austria
•    Biocrates, Austria


1.    https://www.who.int/news-room/fact-sheets/detail/diabetes
2.    https://www.mordorintelligence.com/industry-reports/diabetes-drugs-market
3.    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595349/
4.    https://foodtank.com/news/2016/06/diabetes-rates-are-rising-middle-east/
5.    https://www.marketresearch.com/Mordor-Intelligence-LLP-v4018/Asia-Pacific-Diabetes-Care-Drugs-12475708/
6.    https://www.marketresearch.com/GlobalInfoResearch-v4117/Global-North-America-Europe-Asia-11871303/
7.    https://www.globenewswire.com/news-release/2019/05/28/1851125/0/en/Middle-East-Africa-2793-99-Million-Diabetes-Drugs-Market-to-2024.html
8.    https://www.mordorintelligence.com/industry-reports/europe-diabetes-care-devices-market-industry



Meetings International is announcing Young Scientist Awards through World Summit on Diabetes and Metabolism (Diabetes Metabolism2020) which is scheduled at Toronto, Canada during March 23-24, 2020. This Diabetes Metabolism conference focuses on “Collection of Advanced Therapies: Prevention of Diabetes & Metabolic Syndrome”.

Diabetes Metabolism 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of Diabetes & Endocrinology and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Diabetes Metabolism 2020 focuses mainly on Obesity, Diabetes and Metabolic Syndrome, Diabetes Wound Care, Endocrinology, Cardio metabolic Disease, Pathophysiology, Diabetic Nephropathy, Diabetes Eye Diseases. Diabetes Metabolism conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.


Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee


  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.


  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of  Diabetes Metabolism Conference.



Meetings International has taken an initiative to felicitate attendees with awards to recognise, celebrate and encourage achievement in its various conferences and events. These awards have different committees, nominating procedures and submission deadlines. We salute and acknowledge attainment within an industry that is continuously evolving and re-drawing the boundaries of best practice. These awards represent the pinnacle of professional achievement for event professionals. They recognize Best Eminent Presentation Award, Outstanding Oral Presentation Award, Best Organising Committee Member Award, Outstanding Future Scientist Presentation Award & Best Poster Award. We invite all enthusiastic researchers from all around the world join us for the Diabetes Metabolism conference scheduled during March 23-24, Toronto, Canada.

  • Best Eminent Presentation Award: Diabetes Metabolism will honour the Keynote Speakers who have made significant contributions to the field of Daibetes Healthcare but also makes a difference by his presence during the conference. Recipients of the award are considered to have advanced the field through research or service.



  • Outstanding Oral Presentation Award: There will be a number of technical sessions in the conference under different themes. These awards are provided to the presentations that have been selected to be the best in the particular session. Diabetes Metabolism perceives the individuals who have made significant and imaginative walks in education system. This award will be provided for the most outstanding presentation of the entire conference.


  • Best Organizing Committee Member Award: Diabetes Metabolism will honour the individual who has demonstrated exemplary support and guidance throughout the conference.


  • Outstanding Future Researcher Presentation Award: The Future Researcher Presentation Award will be given to the most outstanding presentation presented by a participant who has registered under the student category. Undergraduates, Master students, and Ph.D. students will be considered under this category. This award recognizes individuals in the early stages of their careers who have already made outstanding research, teaching, and/or service contributions to the field of information systems.


  • Best Poster Award: There will be a poster session at the Diabetes Metabolism and this award is dedicated to the poster presenters in the conference. The best poster presentation will be selected among all the researchers in the session. Recipients of the award are considered to be the Best Poster Presenter of the conference.


The awards given for our Daibetes conferences (conference subject) recognise the wide range of responsibilities and dedication of Diabetes and Diabetes & Endocrinology professionals who promote the highest standards of care across the whole health service. Diabetes Metabolism events make a huge contribution to maintaining and protecting the health and well-being of people across the globe.


  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners will be formally announced during the closing ceremony.
  • The winners of the Poster Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.


  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference
  • Each poster should be approximately 1x1 M long. The title, contents and the author’s information should be clearly visible from a distance of 1-2 feet.


In today’s economic climate your business decisions are as crucial as ever. World Congress on Diabetes & Metabolism conference allows you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. World Congress on Diabetes & Metabolism is organizing an outstanding Scientific Exhibition/Program and anticipates the world’s leading specialists involved in. Diabetes Metabolism 2020 organizing committee anticipates over 300 participants to attend this premier event. Your organization will benefit with excellent exposure to the leaders in Diabetes & Endocrinology. Diabetes Metabolism 2020 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.

Meetings Int. receives 400,000+ online visitors with 1000+ sessions which confirm the outstanding pool of new users and visitors creating a platform to build your market place globally.  Advertise on a platform where all of our conferences are listed to target a large audience of people. Here is your chance to publicize in the site that can interface you to driving specialists and science pros over the Globe.

Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator. Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world.

Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

For further queries, connect our conference manager at diabetesmetabolism@annualmeetings.net; sponsor@meetingsint.com

You can also connect us via WhatsApp: +65 3158 1626 / + 44 122980269

Google Analytics Metrics of Diabetes Metabolism 2020:

  • The visitor’s traffic is the benchmark for the success of conference and Diabetes Metabolism 2020 is constantly attracting viewers across the world.
  • According to the Google Analytics, more than 6000+ monthly audiences are visiting to our conference websites for submitting abstracts; brochure downloads registration, exhibition and sponsorship queries.
  • Readers from the major countries including United States, Japan, United Kingdom, European Union, Asia-Pacific and Middle East visit our conference domain to participate and present their latest research.

Google Analytics Metrics of Meetings International:

  • 437,380 + Users
  • 1,606,987 + Page views
  • 644,430 Sessions at the rate of 1.47 per user

Meetings International has so far received 644,430 Sessions which confirm the outstanding pool of new users and visitors. Meetings International works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers.



  • Obesity, Diabetes and Metabolic Syndrome
  • Diabetes Wound Care and Management
  • Endocrinology and Metabolic Syndrome-Metabolic Disorder
  • Pathophysiology: Endocrinology, Diabetes and Metabolic Syndrome
  • Cardio metabolic Disease
  • Diabetes Diet, Eating, & Physical Activity
  • Diabetes Diagnosis and Treatment
  • Paediatric Diabetes, Diabetes Eye Diseases, Paediatric Endocrinology and Gynaecology Endocrinology
  • Advanced Treatments for Diabetes
  • Diabetic Nephropathy and Urine

6 Organizing Committee Members

1 Renowned Speakers

Yvonne Paul

Professor, Tshwane University of Technology,
South Africa

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner